Country Meeting Agenda
Meeting Objectives:
- Review healthcare system and immunization programs in scope of HPV prevention and control
- Provide a summary of the epidemiology, burden of disease and surveillance related to HPV and HPV-related cancers in Poland
- Discuss the landscape, key issues and challenges related to HPV prevention and control in Poland
- Review countries’ examples for best practices
- Discuss the way forward.
DAY 1 - Thursday, 23 November 2023
SESSION 1: INAUGURAL SESSION
- Welcome & Introduction
Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center)
Prof. Alex Vorsters (University of Antwerp)
(Video)
SESSION 2: HPV-RELATED CANCER BURDEN AND THE HEALTHCARE SYSTEM IN POLAND
Chairs: Dr. Iwona Wrześniewska-Wal (Medical University of Lublin) & Prof. Margaret Stanley (University of Cambridge)
- History of HPV research in Poland: The legacy of Stefania Jabłonska
Prof. Lidia Rudnicka (Medical University of Warsaw) – pre-recorded (Video) - Cervical cancer and HPV related cancer disease burden; country-level overview
Dr. Irmina Michałek (Polish Cancer Registry) (Video, Pdf) - Organization of prevention and control programs within the Polish healthcare system
Prof. Iwona Paradowska-Stankiewicz (National Institute of Public Health – National Institute of Hygiene) (Video, Pdf) - Q&A (Video)
SESSION 3A: HPV EPIDEMIOLOGY AND CERVICAL CANCER SCREENING IN POLAND
Chairs: Prof. Mario Poljak (University of Ljubljana) & Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center)
- Current status of planned HPV-based cervical screening in Poland
Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center) (Video, Pdf) - Standardization of procedures according to the Polish Society of Colposcopy and Cervical Pathophysiology
Prof. Robert Jach (Polish Society of Colposcopy and Cervical pathology) (Video, Pdf) - National Research Institute of Oncology's Initiative: Free Training for Colposcopist in Cervical Cancer screening program
Msc. Julia Jankun (The Maria Sklodowska-Curie National Research Institute of Oncology) (Video, Pdf) - Legal and administrative aspects to consider for organizing a cervical cancer screening program in Poland
Dr. Artur Prusaczyk (Medical and Diagnostic Centre (MDC) (Video, Pdf) - Q&A (Video)
- Desired characteristics of HPV tests for cervical cancer screening and clinical management
Prof. Mario Poljak (University of Ljubljana) (Video, Pdf)
SESSION 3B: PANEL DISCUSSION ON CERVICL CANCER SCREENING: CURRENT CERVICAL CANCER SCREENING PROGRAM (FROM CAPTURE TO TREATMENT AND REPORTING)
Panelists: (Video)
Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center)
Dr. Maciej Stukan (Pomeranian Hospitals)
Prof. Mario Poljak (University of Ljubljana)
Prof. Robert Jach (Polish Society of Colposcopy and Cervical Pathology)
Dr. Dorothy Machalek (University of New South Wales)
Dr. Artur Prusaczyk (Medical and Diagnostic Centre (MDC))
Prof. Mariusz Bidziński (National Cancer Institute)
SESSION 4: OVERVIEW OF HPV-RELATED DISEASE PREVENTION IN POLAND
Chairs: Dr. Talia Malagón (McGill University) & Prof. Jan Kotarski (Medical University in Lublin)
- Challenges on implementation of HPV vaccination programme
Prof. Ernest Kuchar (Polish Society of Vaccinology) - online (Video, Pdf) - Overview of gynecological cancers associated with HPV in Poland
Prof. Maciej Stukan (Pomeranian Hospitals) (Video, Pdf) - Treatment of cervical cancer
Prof. Mariusz Bidziński (National Cancer Institute) (Video, Pdf) - Disease burden, screening and treatment of head and neck cancers in Poland
Dr. Tomasz Szafarowski (Medical University of Warsaw) (Video, Pdf) - Q&A (Video)
SESSION 5A: HPV VACCINATION IN POLAND: ORGANIZATION OF HPV VACCINATION PROGRAM IN POLAND
Chairs: Dr. Artur Prusaczyk (Medical and Diagnostic Centre (MDC)) & Dr. Dorothy Machalek (University of New South Wales)
- Update on HPV vaccination program in Poland ( introduction plan, delivery strategy, communication plan, reporting system) - Organization of the HPV Vaccination Programme in Poland
Joanna Głażewska (Vice Director of the Department of Public Health of the Ministry of Health) (Video, Pdf) - Lessons learned from HPV vaccination programs in other countries: Country example presentation
UK – Dr. Cherstyn Hurley (UK Health Security Agency) - online (Video, Pdf)
Ireland & Denmark – Prof. Alex Vorsters (University of Antwerp) (Video, Pdf) - Q&A (Video)
KEYNOTE SESSION
Chairs: Dr. Artur Prusaczyk (Medical and Diagnostic Centre (MDC)) & Dr. Dorothy Machalek (University of New South Wales)
- Vaginal microbiome, cervical carcinogenesis, probiotics, and other agents
Prof. Mara Kyrgiou (Imperial College London) - online (Video, Pdf) - Q&A
- The Role of Polish Gynaecologists in prevention of HPV-related cancer in Poland
Prof. Piotr Sieroszewski (Medical University of Lodz, Polish Society of Gynecologists and Obstetricians) (Video, Pdf) - Q&A
Day 2 – November 24
OPENING DAY 2
- Opening remarks
SESSION 5B: HPV VACCINATION PROGRAM IN POLAND
Chairs: Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center) & Dr. Sharon Hanley (University of Aberdeen)
- European Beating Cancer Plan: Pathway to HPV Elimination in Europe
Prof. Daniel Kelly (European Cancer Organisation) – online (Video, Pdf) - Current state of HPV vaccine confidence in Europe
Greet Hendrickx (University of Antwerp) (Video, Pdf) - Overcoming Challenges in HPV Vaccination: A Case Study from Wroclaw, Poland
Dr. Kamila Ludwikowska (Wroclaw Medical University) (Video, Pdf) - Reaching HPV vaccination goal through tailored communication interventions
Siff Nielsen (WHO Europe) - Online (Video, Pdf) - Q&A (Video)
SESSION 5C: PANEL DISCUSSION ON HPV VACCINATION: A WELL ORGANIZED HPV VACCINATION PROGRAM IN POLAND - WHAT SHALL WE DO?
Panelists: (Video)
Prof. Iwona Paradowska-Stankiewicz (National Institute of Public Health – National Institute of Hygiene)
Dr. Artur Prusaczyk (Medical and Diagnostic Centre (MDC))
Prof. Daniel Kelly (European Cancer Organisation) – online
Dr. Kamila Ludwikowska (Wroclaw University of Science and Technology)
Dr. Sharon Hanley (University of Aberdeen)
Dr. Dorothy Machalek (University of New South Wales)
Prof. Andrzej Nowakowski (Maria Sklodowska-Curie Institute of Oncology Center)
How to ensure multi-sectoral coordination?, Planning, Communication for high-level stakeholders and community, Advocacy, Addressing Misinformation, Crisis plan and management, training of healthcare professionals
SESSION 6: ROUND TABLE DISCUSSION - PATIENT ADVOCAY GROUPS/IMPLEMENTATION STAKEHOLDERS
- Kwiat Kobiecosci – Dr. Ida Karpińska (Video, Pdf)
SESSION 7: BREAKOUT GROUPS (PEER-TO-PEER LEARNING)
Chairs: HPV Prevention and Control Board
2 topic-focused breakout groups
- Breakout Group 1: HPV Vaccination
Chairs: Dr. Kamila Ludwikowska & Dr. Dorothy Machalek - Breakout Group 2: Cervical Cancer Screening
Chairs: Prof. Mario Poljak & Prof. Andrzej Nowakowski - Plenary Feedback from the Groups
SESSION 8: CONCLUSION
Chairs: Prof. Alex Vorsters & Prof. Andrzej Nowakowski